Glaxosmithkline Share News (GSK)

BROKER RATINGS SUMMARY: Jefferies Starts Premier Oil With Hold

REPEAT: LONDON MORNING BRIEFING: TeleCity Jumps 20% On Takeover Offer

LONDON MORNING BRIEFING: TeleCity Shares Jump 20% On Takeover Offer

AGM, EGM Calendar - Week Ahead

Under pressure, FDA to hold public meeting on off-label use

By Toni Clarke WASHINGTON, May 6 (Reuters) - The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of drugs violate their first amendment right to free speech. The meeting

BUZZ-CoLucid Pharmaceuticals Inc: Plummets in debut after delay, price cut

** Drug developer's shares down 20 pct after IPO carries over into this week ** Stock opens at $8.50, well below $10 IPO price, and descends immediately to as low as $7.56 ** Company redistributed revised prospectus yesterday for sale of 5.5 mln shares at $10, significantly below orig

GSK sees little prospect of U.S. generic Advair in 2016

LONDON, May 6 (Reuters) - After relying for years on its top-selling lung drug Advair, GlaxoSmithKline is now braced for the worst in the form of cheap generics - but not just yet. Chief Executive Andrew Witty said on Wednesday that the chances of cheap copies of its highly profitable inhal

AGM, EGM Calendar - Week Ahead

UPDATE 2-GSK scraps plan to list HIV drugs business and shields dividend

* Reduces cash return to shareholders, protects dividend * Sets mid-term targets for growth of business units * Q1 core EPS 17.3p vs consensus 17.4p * Q1 revenue 5.62 billion pounds, in line with consensus (Adds reaction and context) By Ben Hirschler LONDON, May 6

GSK cuts Novartis payout as first-quarter revenues rise but earnings ease

GlaxoSmithKline posted a modest increase in first-quarter revenue on Wednesday, up 0.2% to £5.62bn from £5.61bn, as the company said it plans to cut the amount of money it will return to shareholders under an asset swap with Novartis. Core operating profit was down 14% on a constant exchange rate ba

UPDATE: Glaxo Slashes Return To Shareholders, Sets Out Growth Guidance

LONDON MIDDAY BRIEFING: Glaxo Slashes Shareholder Payout Plans

Glaxo Slashes Return To Shareholders, Sets Out Guidance Through To 2020

LONDON MARKET COMMENT: Stocks Buoyed By Strong Eurozone, UK PMIs

Glaxo's ViiV Begins Phase III Programme For Dolutegravir/Rilpivirine